Literature DB >> 2893812

Antigen CD34+ marrow cells engraft lethally irradiated baboons.

R J Berenson1, R G Andrews, W I Bensinger, D Kalamasz, G Knitter, C D Buckner, I D Bernstein.   

Abstract

The CD34 antigen is present on 1-4% of human marrow cells including virtually all hematopoietic progenitors detected by in vitro assays. Since the anti-CD34 monoclonal antibody 12-8 reacts with a similar marrow population in baboons, it was possible to test whether this antigen is expressed by stem cells responsible for hematopoietic reconstitution in vivo. CD34+ cells were enriched from marrows of five baboons using avidin-biotin immunoadsorption. After lethal irradiation, the five animals were given 15-27 X 10(6) autologous marrow cells (3.2-4.4 X 10(6) cells/kg) containing 65-91% CD34+ cells. All animals achieved granulocyte counts greater than 1,000/mm3 and platelet counts greater than 20 X 10(3)/mm3 by 13-24 d posttransplant and subsequently developed normal peripheral blood counts. Two additional animals received 184 and 285 X 10(6) marrow cells/kg depleted of CD34+ cells. One animal died at day 29 without engraftment, while the other had pancytopenia for greater than 100 d posttransplant. The data suggest that stem cells responsible for hematopoietic reconstitution are CD34+.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893812      PMCID: PMC442551          DOI: 10.1172/JCI113409

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells.

Authors:  S M Watt; K Karhi; K Gatter; A J Furley; F E Katz; L E Healy; L J Altass; N J Bradley; D R Sutherland; R Levinsky
Journal:  Leukemia       Date:  1987-05       Impact factor: 11.528

2.  Positive selection of viable cell populations using avidin-biotin immunoadsorption.

Authors:  R J Berenson; W I Bensinger; D Kalamasz
Journal:  J Immunol Methods       Date:  1986-07-11       Impact factor: 2.303

3.  The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors.

Authors:  R G Andrews; M Takahashi; G M Segal; J S Powell; I D Bernstein; J W Singer
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

4.  Low temperature preservation of monkey marrow in dimethyl sulfoxide.

Authors:  C D Buckner; R Storb; L A Dillingham; E D Thomas
Journal:  Cryobiology       Date:  1970 Sep-Oct       Impact factor: 2.487

5.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors.

Authors:  R G Andrews; J W Singer; I D Bernstein
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

6.  The influence of culture conditions on the production of colony-stimulating activity by human placenta.

Authors:  T Schlunk; M Schleyer
Journal:  Exp Hematol       Date:  1980-02       Impact factor: 3.084

7.  Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation.

Authors:  R Storb; T C Graham; R B Epstein; G E Sale; E D Thomas
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

8.  Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.

Authors:  C I Civin; L C Strauss; C Brovall; M J Fackler; J F Schwartz; J H Shaper
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

9.  Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption.

Authors:  R J Berenson; W I Bensinger; D Kalamasz; P Martin
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

10.  A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow.

Authors:  R W Tindle; R A Nichols; L Chan; D Campana; D Catovsky; G D Birnie
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

View more
  85 in total

1.  Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy.

Authors:  Z Hou; Q Nguyen; B Frenkel; S K Nilsson; M Milne; A J van Wijnen; J L Stein; P Quesenberry; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 2.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Hematopoietic-stem-cell-based gene therapy for HIV disease.

Authors:  Hans-Peter Kiem; Keith R Jerome; Steven G Deeks; Joseph M McCune
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

4.  Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors.

Authors:  N M Sposi; L I Zon; A Carè; M Valtieri; U Testa; M Gabbianelli; G Mariani; L Bottero; C Mather; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 5.  Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis.

Authors:  Sebastian George Barton Furness; Kelly McNagny
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.

Authors:  Irving L Weissman; Judith A Shizuru
Journal:  Blood       Date:  2008-11-01       Impact factor: 22.113

Review 7.  Specific protein markers for stem cell cross-talk with neighboring cells in the environment.

Authors:  Kyung Soo Park; Seung Won Shin; Jeong-Woo Choi; Soong Ho Um
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

Review 8.  To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma.

Authors:  C Piccoli; F Agriesti; R Scrima; F Falzetti; M Di Ianni; N Capitanio
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture.

Authors:  J J Cornelissen; R E Ploemacher; B W Wognum; A Borsboom; H C Kluin-Nelemans; A Hagemeijer; B Löwenberg
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 10.  Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors.

Authors:  G S Chatta; D C Dale
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.